Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Acute transverse myelitis in a traveler].
In Vivo Gene Transfer to Schwann Cells in the Rodent Sciatic Nerve by Electroporation.
Peripheral and Central Neuroinflammatory Changes and Pain Behaviors in an Animal Model of Multiple Sclerosis.
Injectable Disease Modifying Agents in Multiple Sclerosis: Pattern of Medication Use and Clinical Effectiveness.
>CME/CNE ARTICLE: Severity Grading in Multiple Sclerosis: A Proposal.
Selective and compartmentalized myelin expression of HspB5.
Antibodies to myelin basic protein are associated with cognitive decline after stroke.
PDCD1 PD-1.3 polymorphism and allergic bronchial asthma in Russian and Buryat patients.
Vascularized nerve grafts: an experimental study.
Progressive ataxia in a natalizumab-treated multiple sclerosis patient: the dark side of JC virus infection.
The emerging role of p38 MAP kinase in multiple sclerosis and its models.
Longitudinal changes in sickness absence and disability pension, and associations between disability pension and disease-specific and contextual factors and functioning, in people with multiple sclerosis.
Plasma exchange therapy for a severe relapse of Devic's disease in a pregnant woman: A case report and concise review.
Inflammaging and Frailty Status Do Not Result in an Increased Extracellular Vesicle Concentration in Circulation.
Peculiarities of Neurological Disorders and Study Designs.
What is the future of proof of concept studies in multiple sclerosis?
Resolvin D1 Programs Inflammation Resolution by Increasing TGF-β Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis.
Therapeutic antibodies for spinal cord injury.
Disease Activity and Conversion into Multiple Sclerosis after Optic Neuritis Is Treated with Erythropoietin.
Cognitive status in patients with multiple sclerosis in Lanzarote.
Autoimmunity in 2015.
How have research questions and methods used in clinical trials published in Clinical Rehabilitation changed over the last 30 years?
Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system.
Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis.
Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS.

Pages